WELCOME | EXECUTIVE SUMMARY | KEY FIGURES | SCIENTIFIC PROGRAMME | SPONSOR BENEFITS | RESOURCES

WHAT MAKES EULAR UNIQUE?

EULAR ABSTRACT HISTORY 2011 – 2021

TOP 10 COUNTRIES AT EULAR 2021 VIRTUAL CONGRESS ATTENDEES

ATTENDANCE BETWEEN 2011 AND 2021

EXHIBITOR PHYSICAL PRESENCE BETWEEN 2011 AND 2021 (data per sqm)

WHO EXHIBITED AT THE EULAR 2021 vIRTUAL CONGRESS?

AbbVie

AMGEN

AstraZeneca

Biogen International GmbH

Boehringer Ingelheim Pharma GmbH & Co. KG

Bristol-Myers Squibb UPSA

Celltrion Healthcare Co. Ltd.

Cytokine Signalling Forum
Fresenius Kabi SwissBioSim

Galapagos

Gilead Sciences

IBSA Institut Biochimique SA

INTERNATIONAL MEDICAL PRESS

Janssen

Lilly

medac GmbH

Nordic Pharma

Novartis Pharma AG

Pfizer Pharmaceutical Group

Hoffmann-La Roche Ltd.

R-Pharm

Sanofi Genzyme

sobi

UCB Pharma SA

Vifor Fresenius Medical Care Renal Pharma Ltd.

... and 83 not-for profit organisations.

About EULAR 2022 Congress

The aim of the European Congress of Rheumatology is to provide a forum of the highest standard for scientific (both clinical and basic), educational and social exchange between professionals involved in rheumatology, liaising with patient organisations, in order to achieve progress in the clinical care of people with rheumatic diseases.

About EULAR

The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the patient, health professional and scientific societies of rheumatology of all the European nations. EULAR endeavors to stimulate, promote, and support the research, prevention, treatment and rehabilitation of rheumatic diseases. In line with UEMS, EULAR defines rheumatology as including rheumatic diseases of the connective tissue, locomotor and musculoskeletal systems.

Key Figures